Videos

Conference Coverage

Sequential Therapy vs Triplet Therapy for Patients With Newly Diagnosed AML Ineligible for Intensive Chemotherapy

04/09/2024

Featuring Jessica Altman, MD

During the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Jessica Altman, MD, argues in favor of using sequential therapy over triplet therapy for patients with newly diagnosed acute myeloid leukemia who are ineligible for...

During the 2024 Great Debates &...

04/09/2024

Oncology

Videos

Mortality After Amputation: Putting Evidence Into Practice

04/09/2024

Featuring Jakob Thorud, DPM, MS, FACFAS

Featuring Jakob Thorud, DPM, MS, FACF...

In a companion to his cover feature, this author expounds on the most important things DPMs should know about amputation and mortality, and how you can use the evidence in your practice.

In a companion to his cover...

04/09/2024

Podiatry Today

Conference Coverage

Analyzing Comprehensive Health of Patients With Multiple Myeloma for Transplant Decision-Making

04/08/2024

Featuring Ashley Rosko, MD

At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Ashley Rosko, MD, discusses why the comprehensive health of patients with multiple myeloma should be analyzed to make transplant decisions, rather than only focusing on...

At the 2024 Great Debates &...

04/08/2024

Oncology

Clinical Videos

Wire Entanglement to Retrieve Dislodged Stent From the Proximal Right Coronary Artery

04/08/2024

Basavanna Dinesh, MD, DM; Yamasandi Siddegowda Shrimanth, MD, DM; Aditha Cibi, MD; Kanchanahalli Siddegowda Sadananda, MD, DM; Snehal Jayarama,MD, DrNB; Khandenahally Shankarappa Ravindranath, MD, DM

Basavanna Dinesh, MD, DM; Yamasandi S...

Video Supplement to "Wire Entanglement to a Retrieve Dislodged Stent From the Proximal Right Coronary Artery" (Clinical Image).

Video Supplement to "Wire...

04/08/2024

Journal of Invasive Cardiology

Conference Coverage

Mitigating Risk of Infection While Using BCMA Bispecific Antibodies as Treatment

04/08/2024

Featuring Andrew Yee, MD

At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Yee, MD, speaks about mitigating the risks of infection while using BCMA bispecific antibodies as treatment.

At the 2024 Great Debates &...

04/08/2024

Lymphoma, Leukemia & Myeloma Network

Conference Coverage

Should Additional BCMA Therapy be Utilized After Previous BCMA Therapy?

04/08/2024

Featuring Andrew Yee, MD

At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Yee, MD, discusses whether or not it is suitable for a patient to receive additional BCMA therapy after previous BCMA therapy.

At the 2024 Great Debates &...

04/08/2024

Oncology

Videos

Navigating the Bacillus Calmette-Guerin Shortage for Patients With High-Risk Non-Muscle Invasive Bladder Cancer

04/08/2024

Featuring Andrew Katims, MD, MPH

Featuring Andrew Katims, MD, MPH ...

Andrew Katims, MD, discusses the challenges of treating patients with high-risk non-muscle invasive bladder cancer during the bacillus Calmette-Guerin shortage.

Andrew Katims, MD, discusses the...

04/08/2024

Oncology

Sponsored Video

Real-World Evidence and Secondary Mechanism of Action of the Auryon Laser System

04/08/2024

A discussion with John Rundback, MD, and Bulent Arslan, MD

A discussion with John Rundback, MD, ...

Learn about the recently published safety and efficacy data of the Auryon Laser System.

Learn about the recently...

04/08/2024

Vascular Disease Management

Videos

How Health Care Stakeholders in Oncology Can Prepare for and Manage Drug Shortages

04/08/2024

Featuring Erin Fox, PharmD

Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.

Erin Fox, PharmD, shares steps...

04/08/2024

Journal of Clinical Pathways

Conference Coverage

Influence of Targeted Agents in the Treatment of Chronic Lymphocytic Leukemia

04/06/2024

Featuring John Allan, MD

At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, John Allan, MD, shares expert insight on the impact targeted agents have in the treatment of CLL, focusing particularly on frontline therapy.

At the 2024 Great Debates &...

04/06/2024

Oncology